Table 1 In vitro resistance results of pneumonia and nonpneumonia-related A. baumannii bacteremia

Levofloxacin

Ceftazidime

Imipenem

Piperacillin/ tazobactam

Ciprofloxacin

Minocycline

Tobramycin

Meropenem

Cefepime

Ticarcillin/ clavulanic

acid

Cefopetazone/ sulbactam

Doxycycline

Compound Xinnuomin

Amikacin

Tigecycline

Colistin

CR-AB

MDR-AB

50.4%(59/117)

60.6%(71/117)

58.9%(69/117)

67%(67/100)

60.75%(65/107)

16.48%(15/91)

54.2%(58/107)

78.89%(62/90)

55.5%(65/117)

70%(63/90)

52.94%(54/102)

57.14%(52/91)

48.7%(57/117)

17.39%(4/23)

5.88%(6/102)

3.37%(3/91)

58.97%(69/117)

61.53%(72/117)

77.7%(35/45)

82.2%(37/45)

80%(36/45)

83.72%(36/43)

86.05%(37/43)

26.83%(11/41)

76.74%(33/43)

77.7%(35/45)

75.5%(34/45)

85.36%(35/41)

69.76%(30/43)

73.17%(30/41)

60%(27/45)

40%(2/5)

6.98%(3/43)

2.44%(1/41)

80%(36/45)

84.44%(38/45)

33.3%(24/72)

47.2%(34/72)

45.8%(33/72)

54.38%(31/57)

43.75%(28/64)

8%(4/50)

39.07%(25/64)

56%(28/50)

43%(31/72)

57.14%(28/49)

40.68%(24/59)

44%(22/50)

41.6%(30/72)

11.11%(2/18)

5.08%(3/59)

4.17%(2/48)

45.83%(33/72)

47.22%(34/72)

21.88

14.21

8.03

9.54

19.29

5.8

15.29

8.72

11.84

8.46

3.44

7.82

3.72

2.27

0.15

0.20

13.36

16.21

0

0

0.006

0.03

0

0.023

0

0.005

0.001

0.004

0.005

0.006

0.06

0.19

0.69

1

0

0